August 7, 2014 / 10:33 AM / 3 years ago

Auxilium Pharma posts bigger-than-expected quarterly loss

Aug 7 (Reuters) - Drugmaker Auxilium Pharmaceuticals posted a much bigger-than-expected quarterly loss, hurt by falling sales of testosterone gel Testim.

Auxilium lost $36.5 million, or 73 cents per share, in the second quarter ended June 30, compared with a net profit of $42.7 million, or 86 cents per share, a year earlier.

Excluding items, the loss was 44 cents per share.

Analysts on average had expected the company to post a loss of 21 cents a share, according to Thomson Reuters I/B/E/S.

Total revenue fell 17.4 percent to $83 million. (Reporting by Anjali Rao Koppala in Bangalore; Editing by Saumyadeb Chakrabarty)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below